NARDIN, CHIARA
NARDIN, CHIARA
Blood Pressure Variability and Therapeutic Implications in Hypertension and Cardiovascular Diseases
2019 Nardin, C.; Rattazzi, M.; Pauletto, P.
L-Arginine prevents inflammatory and pro-calcific differentiation of interstitial aortic valve cells
2020 Rattazzi, M.; Donato, M.; Bertacco, E.; Millioni, R.; Franchin, C.; Mortarino, C.; Faggin, E.; Nardin, C.; Scarpa, R.; Cinetto, F.; Agostini, C.; Ferri, N.; Pauletto, P.; Arrigoni, G.
Lipid Profile and Vascular Remodelling in Young Dyslipidemic Subjects Treated with Nutraceuticals Derived from Red Yeast Rice
2021 Puato, Massimo; Zambon, Alberto; Nardin, Chiara; Faggin, Elisabetta; Pesavento, Raffaele; Spinazzè, Alice; Pauletto, Paolo; Rattazzi, Marcello
Serum uric acid levels and the risk of recurrent venous thromboembolism
2021 De Lucchi, L.; Nardin, C.; Sponchiado, A.; Raggi, D.; Faggin, E.; Martini, E.; Pagliara, V.; Callegari, E.; Caberlotto, L.; Plebani, M.; Pauletto, P.; Cinetto, F.; Agostini, C.; Villalta, S.; Rattazzi, M.
Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives
2020 Felice, C; Nardin, C; Di Tanna, G L; Grossi, U; Bernardi, E; Scaldaferri, L; Romagnoli, M; Tonon, L; Cavasin, P; Novello, S; Scarpa, R; Farnia, A; De Menis, E; Rigoli, R; Cinetto, F; Pauletto, P; Agostini, C; Rattazzi, M
Vascular remodelling in well-controlled hypertensive patients: the challenge of residual risk management
2017 Puato, Massimo; Nardin, Chiara; Zanon, Marta; Palatini, Paolo; Pauletto, Paolo; Rattazzi, Marcello
Warfarin, but not rivaroxaban, promotes the calcification of the aortic valve in ApoE−/− mice
2018 Rattazzi, M; Faggin, E; Bertacco, E; Nardin, C; Pagliani, L3; Plebani, Mario; Cinetto, F; Guidolin, D4; Puato, M; Pauletto, P